Department of Gynaecology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan Province, China.
BMC Womens Health. 2023 Mar 24;23(1):127. doi: 10.1186/s12905-023-02269-4.
Polycystic ovary syndrome (PCOS) is characterized by anovulation, insufficient progesterone, hyperandrogenism, and insulin resistance. These factors can disrupt the endometrium of PCOS patients and can lead to chronic low-grade inflammation in the endometrium, endometrial hyperplasia, or even endometrial cancer.
The aim of this study was to investigate the prevalence of premalignant and malignant endometrial polyps in premenopausal women and to further explore whether PCOS is associated with premalignant and malignant changes in endometrial polyps.
This study was conducted by retrieving the medical data of 4236 premenopausal women who underwent hysteroscopic polypectomies between January 2015 and December 2021. Demographic and clinical data regarding age, height, weight, parity, hormone replacement therapy, oral contraceptives, abnormal uterine bleeding, hypertension, diabetes mellitus, PCOS, number of polyps, and size of polyps were collected, and their associations with premalignant and malignant changes in endometrial polyps were analysed.
Among the endometrial polyps removed by hysteroscopic polypectomy in premenopausal women, the prevalence of premalignant and malignant polyps was 2.15%, which comprised hyperplasia with atypia at 1.13% and endometrial carcinoma at 1.02%. PCOS was associated with a higher risk of premalignant and malignant endometrial polyps in premenopausal women after adjustment for potential confounding factors.
PCOS is associated with a higher risk of premalignant and malignant endometrial polyps in premenopausal women. Therefore, it is important to evaluate the endometrium in PCOS patients with ultrasonography or hysteroscopy, and active management involving hysteroscopic polypectomy should be offered to PCOS patients diagnosed with endometrial polyps regardless of symptoms.
多囊卵巢综合征(PCOS)的特征为排卵障碍、孕激素不足、高雄激素血症和胰岛素抵抗。这些因素会破坏 PCOS 患者的子宫内膜,导致子宫内膜发生慢性低度炎症、子宫内膜增生,甚至子宫内膜癌。
本研究旨在探讨绝经前妇女子宫内膜息肉的癌前和恶性病变的发生率,并进一步探讨 PCOS 是否与子宫内膜息肉的癌前和恶性变化有关。
本研究通过检索 2015 年 1 月至 2021 年 12 月间行宫腔镜息肉切除术的 4236 例绝经前妇女的医疗数据进行。收集年龄、身高、体重、产次、激素替代治疗、口服避孕药、异常子宫出血、高血压、糖尿病、PCOS、息肉数量和息肉大小等人口统计学和临床数据,并分析其与子宫内膜息肉癌前和恶性变化的关系。
在绝经前妇女宫腔镜切除的子宫内膜息肉中,癌前和恶性息肉的发生率为 2.15%,其中包括增生伴不典型增生 1.13%和子宫内膜癌 1.02%。调整潜在混杂因素后,PCOS 与绝经前妇女发生癌前和恶性子宫内膜息肉的风险增加相关。
PCOS 与绝经前妇女发生癌前和恶性子宫内膜息肉的风险增加相关。因此,对于 PCOS 患者,重要的是通过超声或宫腔镜评估子宫内膜,并对诊断为子宫内膜息肉的 PCOS 患者无论有无症状,均应提供宫腔镜息肉切除术等积极的管理。